Does the presence of obstructive non-infarct-related artery disease increase 30-day mortality in patients presenting with STEMI?
Patients presenting with ST-elevation myocardial infarction (STEMI) from a pooled analysis of 8 clinical trials
Presence of obstructive non-infarct-related artery (non-IRA) disease
30-day mortalityhard clinical
Obstructive non-infarct-related artery disease is common in STEMI patients and is associated with a modest increase in 30-day mortality, raising questions about the optimal timing and appropriateness of non-IRA revascularization.
In a retrospective pooled analysis of 8 clinical trials, obstructive non-IRA disease was common among patients presenting with STEMI, and was associated with a modest statistically significant increase in 30-day mortality. These findings require confirmation in prospectively designed studies, but raise questions about the appropriateness and timing of non-IRA revascularization in patients with STEMI.
Building similarity graph...
Analyzing shared references across papers
Loading...
Park et al. (Sun,) studied this question.
synapsesocial.com/papers/69b32bdcd4fb4cf4986501bd — DOI: https://doi.org/10.1001/jama.2014.15095
Duk‐Woo Park
Interventional Cardiology
Robert M. Clare
Heart Failure & Transplant
Phillip J. Schulte
Heart Failure & Transplant
JAMA
Stanford University
University of Alberta
Duke Medical Center
Building similarity graph...
Analyzing shared references across papers
Loading...